Phase 2 Mayo Ultrasound Marker: Enhancing lymph node imaging via twinkling artifact

This trial evaluates the safety and ultrasound performance of an optimized marker in women with biopsy-confirmed, node-positive breast cancer. Using ultrasound-guided placement followed by imaging and surgical resection, the study aims to improve consistent marker visibility and surgical planning, addressing a key challenge in breast cancer management at Mayo Clinic.